Is It Too Late To Consider Buying Yatharth Hospital & Trauma Care Services Limited (NSE:YATHARTH)?
While Yatharth Hospital & Trauma Care Services Limited (NSE:YATHARTH) might not have the largest market cap around , it had a relatively subdued couple of weeks in terms of changes in share price, which continued to float around the range of ₹793 to ₹871. However, is this the true valuation level of the small-cap? Or is it currently undervalued, providing us with the opportunity to buy? Let’s take a look at Yatharth Hospital & Trauma Care Services’s outlook and value based on the most recent financial data to see if there are any catalysts for a price change.
What's The Opportunity In Yatharth Hospital & Trauma Care Services?
According to our price multiple model, which makes a comparison between the company's price-to-earnings ratio and the industry average, the stock price seems to be justfied. We’ve used the price-to-earnings ratio in this instance because there’s not enough visibility to forecast its cash flows. The stock’s ratio of 47.83x is currently trading slightly above its industry peers’ ratio of 43.02x, which means if you buy Yatharth Hospital & Trauma Care Services today, you’d be paying a relatively sensible price for it. And if you believe that Yatharth Hospital & Trauma Care Services should be trading at this level in the long run, then there should only be a fairly immaterial downside vs other industry peers. Furthermore, Yatharth Hospital & Trauma Care Services’s share price also seems relatively stable compared to the rest of the market, as indicated by its low beta. This may mean it is less likely for the stock to fall lower from natural market volatility, which suggests less opportunities to buy moving forward.
See our latest analysis for Yatharth Hospital & Trauma Care Services
Can we expect growth from Yatharth Hospital & Trauma Care Services?
Future outlook is an important aspect when you’re looking at buying a stock, especially if you are an investor looking for growth in your portfolio. Buying a great company with a robust outlook at a cheap price is always a good investment, so let’s also take a look at the company's future expectations. With profit expected to more than double over the next couple of years, the future seems bright for Yatharth Hospital & Trauma Care Services. It looks like higher cash flow is on the cards for the stock, which should feed into a higher share valuation.
What This Means For You
Are you a shareholder? YATHARTH’s optimistic future growth appears to have been factored into the current share price, with shares trading around industry price multiples. However, there are also other important factors which we haven’t considered today, such as the track record of its management team. Have these factors changed since the last time you looked at YATHARTH? Will you have enough conviction to buy should the price fluctuate below the industry PE ratio?
Are you a potential investor? If you’ve been keeping an eye on YATHARTH, now may not be the most advantageous time to buy, given it is trading around industry price multiples. However, the positive outlook is encouraging for YATHARTH, which means it’s worth diving deeper into other factors such as the strength of its balance sheet, in order to take advantage of the next price drop.
Since timing is quite important when it comes to individual stock picking, it's worth taking a look at what those latest analysts forecasts are. At Simply Wall St, we have the analysts estimates which you can view by clicking here.
If you are no longer interested in Yatharth Hospital & Trauma Care Services, you can use our free platform to see our list of over 50 other stocks with a high growth potential.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.